ADA講者爲您解析新型降糖藥心腎管理意義——“ 2020 ADA精粹中國行”走進天津朱憲彝紀念醫院
ADA特邀講者爲您解析新型降糖藥！
參考文獻：
1. Marso SP. N Engl J Med. 2016 Sep 16; 375:311-322;Marso SP. N Engl J Med. 2016 Sep 16; 375:311-322;
2. Marso SP, et al. N Engl J Med. 2016;375(19):1834-1844;
3. Hernandez AF, et al. Lancet. 2018;392(10157):1519-1529.
4. Gerstein HC, et al. Lancet. 2019;394(10193):121-130.
5. Merchenthaler I et al. J Comp Neurol 1999;403:261–280.
6. Baggio LL, Drucker DJ. Gastroenterology 2007;132:2131–2157.
7. Ban K et al. Circulation 2008;117:2340–2350.
8. Vrang N et al. Prog Neurobiol 2010;92:442–462.
9. Pyke C et al. Endocrinology 2014;155:1280–1290
10. Drucker DJ. Cell Metab 2016;24:15–30
11. Andersen A et al., Nat Rev Endocrinol. 2018 Jul;14(7):390-403.
12. Nauck, MA, et al. Circulation. 2017 Aug 29;136(9):849-870.
13. Sanada JP, et al. Diabetes 2020 Jun; 69 (Supplement 1): 1435-P.
14. USRDS 2016 Annual Data Report.
15.American Diabetes Association. Diabetes Care 2020;43(Suppl. 1):S135–S151.
16.KDIGO Clinical Practice Guideline on Diabetes Management in Chronic Kidney Disease, 2019.
17.Toyama T, et al. Diabetes Obes Metab. 2019 May;21(5):1237-1250.
18.Shaw JE, et al. Diabetes. 2020.Jun;69（Supplement 1):356-OR.
19.Pfeffer MA, et al. N Engl J Med. 2015;373(23):2247-2257.
20.Holman RR, et al. N Engl J Med. 2017;377(13):1228-1239.
21.Zinman B, et al. N Engl J Med. 2015;373(22):2117-2128.
22.Neal B, et al. N Engl J Med. 2017;377(7):644-657.
23.Wiviott SD, et al. N Engl J Med. 2019;380(4):347-357.
24.Gerstein HC, et al. Lancet Diabetes Endocrinol. 2020 Feb;8(2):106-114.
25.Kristensen SL, et al. Lancet Diabetes Endocrinol. 2019 Oct;7(10):776-785.
爲了更好了解臨牀需求， 請您填寫此問卷，
感謝您的反饋和支持！
版權申明